LingyiMed Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Early Stage VC
- Investors
-
10
LingyiMed General Information
Description
Developer of biotechnology materials designed for pharmaceutical research and clinical application purposes. The company operates a functional validation platform for rare disease animal models dedicated to innovated source, focusing on metabolic, CNS, ophthalmic, and other genetic rare diseases, enabling effective detection of rare disease in animals.
Contact Information
Website
www.lingyimed.comCorporate Office
- Room 1006, Building 7, Phase I, Qianwan Bioport
- Number 3300 Benjing Avenue, Ningwei Street, Xiaoshan District
- Hangzhou, Zhejiang 900000
- China
Corporate Office
- Room 1006, Building 7, Phase I, Qianwan Bioport
- Number 3300 Benjing Avenue, Ningwei Street, Xiaoshan District
- Hangzhou, Zhejiang 900000
- China
LingyiMed Timeline
LingyiMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Early Stage VC | 04-Dec-2025 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 16-Jul-2025 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A1) | 25-Nov-2024 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 27-Jul-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 05-May-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 09-Jun-2022 | $14.9M | $14.9M | Completed | Generating Revenue | |
| 1. Early Stage VC | 05-Aug-2021 | Completed | Startup |
LingyiMed Signals
LingyiMed Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hangzhou Capital | Government | Minority | ||
| Zhejiang Jolly Pharmaceutical Company | Corporation | Minority | ||
| Gisway | Corporation | Minority | ||
| HJ-Investment | Venture Capital | Minority | ||
| Holley Group | Corporation | Minority |
LingyiMed FAQs
-
When was LingyiMed founded?
LingyiMed was founded in 2021.
-
Where is LingyiMed headquartered?
LingyiMed is headquartered in Hangzhou, China.
-
What is the size of LingyiMed?
LingyiMed has 40 total employees.
-
What industry is LingyiMed in?
LingyiMed’s primary industry is Biotechnology.
-
Is LingyiMed a private or public company?
LingyiMed is a Private company.
-
What is LingyiMed’s current revenue?
The current revenue for LingyiMed is .
-
How much funding has LingyiMed raised over time?
LingyiMed has raised $29.4M.
-
Who are LingyiMed’s investors?
Hangzhou Capital, Zhejiang Jolly Pharmaceutical Company, Gisway, HJ-Investment, and Holley Group are 5 of 10 investors who have invested in LingyiMed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process